Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.
Nat Commun. 2024 Feb 24;15(1):1703. doi: 10.1038/s41467-024-45902-y.
Nat Commun. 2024.
PMID: 38402212
Free PMC article.
Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma.
Kowalczyk JT, Wan X, Hernandez ER, Luo R, Lyons GC, Wilson KM, Gallardo DC, Isanogle KA, Robinson CM, Mendoza A, Heske CM, Chen JQ, Luo X, Kelly AE, Difilippantinio S, Robey RW, Thomas CJ, Sackett DL, Morrison DK, Randazzo PA, Jenkins LMM, Yohe ME.
Kowalczyk JT, et al.
Mol Cancer Ther. 2021 Feb;20(2):307-319. doi: 10.1158/1535-7163.MCT-20-0525. Epub 2020 Nov 6.
Mol Cancer Ther. 2021.
PMID: 33158997
Free PMC article.
Item in Clipboard
Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation.
Fabian KP, Kowalczyk JT, Reynolds ST, Hodge JW.
Fabian KP, et al. Among authors: kowalczyk jt.
Cells. 2022 Nov 29;11(23):3826. doi: 10.3390/cells11233826.
Cells. 2022.
PMID: 36497086
Free PMC article.
Review.
Item in Clipboard
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12.
Franks SE, Santiago-Sanchez GS, Fabian KP, Solocinski K, Chariou PL, Hamilton DH, Kowalczyk JT, Padget MR, Gameiro SR, Schlom J, Hodge JW.
Franks SE, et al. Among authors: kowalczyk jt.
Cancer Immunol Immunother. 2023 Aug;72(8):2783-2797. doi: 10.1007/s00262-023-03459-7. Epub 2023 May 11.
Cancer Immunol Immunother. 2023.
PMID: 37166485
Free PMC article.
Item in Clipboard
Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies.
Lopez DC, Robbins YL, Kowalczyk JT, Lassoued W, Gulley JL, Miettinen MM, Gallia GL, Allen CT, Hodge JW, London NR Jr.
Lopez DC, et al. Among authors: kowalczyk jt.
Front Oncol. 2022 Oct 21;12:1012058. doi: 10.3389/fonc.2022.1012058. eCollection 2022.
Front Oncol. 2022.
PMID: 36338744
Free PMC article.
Item in Clipboard
Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence.
Lopez DC, Fabian KP, Padget MR, Robbins YL, Kowalczyk JT, Lassoued W, Pastor DM, Allen CT, Gallia GL, Gulley JL, Hodge JW, London NR Jr.
Lopez DC, et al. Among authors: kowalczyk jt.
Front Oncol. 2024 Apr 29;14:1376622. doi: 10.3389/fonc.2024.1376622. eCollection 2024.
Front Oncol. 2024.
PMID: 38741774
Free PMC article.
Item in Clipboard
Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies.
Kowalczyk JT, Fabian KP, Padget MR, Lopez DC, Hoke AT, Allen CT, Hermsen M, London NR Jr, Hodge JW.
Kowalczyk JT, et al.
J Immunother Cancer. 2022 Dec;10(12):e005752. doi: 10.1136/jitc-2022-005752.
J Immunother Cancer. 2022.
PMID: 36564129
Free PMC article.
Item in Clipboard
Cite
Cite